ASSESSMENT OF THE LEVEL OF ADHERENCE TO TREATMENT IN PATIENTS WITH HYPERTENSION ACCORDING TO THE RESULTS OF THE “STEPS” STUDY
Abstract
According to the World Health Organization (WHO), arterial hypertension (H) is considered a non-infectious pandemic that affects the socio-economic losses of society. The prevalence of hypertension in the world is quite high and amounts to 30-45% among the adult population; increases with age and reaches 62% in persons over 60 years of age [1]. Despite numerous studies on the diagnosis and treatment of arterial hypertension, the availability of various treatment methods and a large selection of drugs and their combinations, it is still not possible to prevent the development of cardiovascular complications (myocardial infarction, stroke), which lead to patient disability and premature mortality [2].
References
WHO fact sheet. Non-communicable diseases. Key Facts. Geneva: World Health Organization; 2018, accessed July 27, 2022.
GBD 2015 Risk Factors Collaborators. Global, regional, and national comparative risk assessment of 79 behavioral, environmental and occupational, and metabolic risks or clusters of risks, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet, 2016;
Project “Improving the Health System (Health-3)” of the Ministry of Health and the World Bank, World Health Organization. Report “Prevalence of risk factors for non-communicable diseases in the Republic of Uzbekistan” (WHO STEPS, 2014). Copenhagen: WHO Regional Office for Europe; 2015.
STEPS: Prevalence of risk factors for non-communicable diseases in the Republic of Uzbekistan, 2019.
